Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT05529992 |
| Consolidated Lead Sponsor | Takeda |
| Therapeutic Condition Cohort | Rare Genetic, Women's Health, and Other |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | COMPLETED |
| Registered Enrollment | 20 participants (ACTUAL) |
| Registered Start Date | 2023-01-03 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Chinese PLA General Hospital | Beijing, China | Open Hospital Dossier -> |
| Beijing Children's Hospital, Capital Medical University | Beijing, China | Open Hospital Dossier -> |
| Lanzhou University Second Hospital | Lanzhou, China | Open Hospital Dossier -> |
| The First Affiliated Hospital, Sun-Yat Sen University | Guangzhou, China | Open Hospital Dossier -> |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Takeda across sibling Meru public-data platforms.
Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.